secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2024-03-18T23:59:59+00:00
Accession:  0001493152-24-010300
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PURE Bioscience Q2 net product sales $325K, net loss $1.0M; shifting to distributor model
--------------------------------------------------------------------------------

- Net product sales $325K in Q2 FY2024, down 18% from $396K YoY; net loss $1.002M vs $1.060M.
- Q2 net loss per share ($0.01); six-month net product sales $1.043M, up 21% from $863K.
- CEO cites unexpected interruption in product flow to one major customer as cause of revenue shortfall.
- Company shifting from direct sales to distributor model to expand market coverage and accelerate growth.
- New food segments and dairy/animal health show interest; registered to exhibit at IAFP July 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315224010300/0001493152-24-010300-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315224010300/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-010300

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer